We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Draft Guidance Broadens Authority of IRBs for Continuing Reviews
Draft Guidance Broadens Authority of IRBs for Continuing Reviews
January 20, 2010
To bolster its efforts to improve the quality of clinical research, the FDA for the first time in 12 years has formally blessed substantially broader power
for IRBs.